This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2006 Jun 17;367(9527):1955-6.

doi: 10.1016/S0140-6736(06)68857-0.

The risk of treatment versus the risk of HIV replication

Steven G Deeks¹

Affiliations

PMID: 16782465
DOI: 10.1016/S0140-6736(06)68857-0

Comment

The risk of treatment versus the risk of HIV replication

Steven G Deeks. Lancet. 2006.

. 2006 Jun 17;367(9527):1955-6.

doi: 10.1016/S0140-6736(06)68857-0.

Author

Steven G Deeks¹

Affiliation

¹ San Francisco General Hospital, San Francisco, California 94110, USA. sdeeks@php.ucsf.edu

PMID: 16782465
DOI: 10.1016/S0140-6736(06)68857-0

No abstract available

PubMed Disclaimer

Comment on

CD4-guided structured antiretroviral treatment interruption strategy in HIV-infected adults in west Africa (Trivacan ANRS 1269 trial): a randomised trial.
Danel C, Moh R, Minga A, Anzian A, Ba-Gomis O, Kanga C, Nzunetu G, Gabillard D, Rouet F, Sorho S, Chaix ML, Eholié S, Menan H, Sauvageot D, Bissagnene E, Salamon R, Anglaret X; Trivacan ANRS 1269 trial group. Danel C, et al. Lancet. 2006 Jun 17;367(9527):1981-9. doi: 10.1016/S0140-6736(06)68887-9. Lancet. 2006. PMID: 16782488 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information